Circular RNA as emerging precision therapeutics: from RNA regulation to peptide translation

Abstract

Circular RNAs (circRNAs) are a class of endogenous non-coding RNAs characterized by a covalently closed-loop structure. Although initially regarded as splicing byproducts, circRNAs are now recognized as essential regulators of gene and protein expression and play important roles in various human diseases. In recent years, growing evidence has indicated that a subset of circRNAs can be translated through cap-independent mechanisms to produce bioactive peptides or proteins. These findings expand the functional scope of circRNAs and offer new opportunities for RNA therapy. This review summarizes recent advances in circRNA biology, with an emphasis on their potential in diagnosis and treatment. We also review the therapeutic strategies targeting circRNAs at both the RNA and protein levels and the delivery systems that support circRNA-directed therapies. After we discuss how circRNA therapeutics may be integrated into precision medicine, we further highlight the current clinical progress and key challenges for advancing circRNA-based therapies toward clinical application.

Keywords

circular RNA / circRNA / RNA biology / oncogenesis / therapy

References

[1] Memczak S, Jens M, Elefsinioti A et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature 2013; 495:333-8. https://doi.org/10.1038/nature11928

[2] Jeck WR, Sorrentino JA, Wang K et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA 2013; 19:141-57. https://doi.org/10.1261/rna.035667.112

[3] Hsu MT, Coca-Prados M. Electron microscopic evidence for the circular form of RNA in the cytoplasm of eukaryotic cells. Nature 1979; 280:339-40. https://doi.org/10.1038/280339a0

[4] Salzman J, Gawad C, Wang PL et al. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS One 2012; 7:e30733. https://doi.org/10.1371/journal.pone.0030733

[5] Kristensen LS, Andersen MS, Stagsted LVW et al. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet 2019; 20:675-91. https://doi.org/10.1038/s41576-019-0158-7

[6] Enuka Y, Lauriola M, Feldman ME et al. Circular RNAs are long-lived and display only minimal early alterations in response to a growth factor. Nucleic Acids Res 2016; 44:1370-83. https://doi.org/10.1093/nar/gkv1367

[7] Li Y, Zheng Q, Bao C et al. Circular RNA is enriched and stable in exosomes: a promising biomarker for cancer diagnosis. Cell Res 2015; 25:981-4. https://doi.org/https://doi.org/10.1038/cr.2015.82

[8] Rybak-Wolf A, Stottmeister C, Glazar P et al. Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed. Mol Cell 2015; 58:870-85. https://doi.org/10.1016/j.molcel.2015.03.027

[9] Vo JN, Cieslik M, Zhang Y et al. The landscape of circular RNA in cancer. Cell 2019; 176:869-81. https://doi.org/10.1016/j.cell.2018.12.021

[10] Misir S, Wu N, Yang BB. Specific expression and functions of circular RNAs. Cell Death Differ 2022; 29:481-91. https://doi.org/10.1038/s41418-022-00948-7

[11] Hansen TB, Jensen TI, Clausen BH et al. Natural RNA circles function as efficient microRNA sponges. Nature 2013; 495:384-8. https://doi.org/10.1038/nature11993

[12] Du WW, Yang W, Chen Y et al. Foxo3 circular RNA promotes cardiac senescence by modulating multiple factors associated with stress and senescence responses. Eur Heart J 2017; 38:1402-12. https://doi.org/10.1093/eurheartj/ehw001

[13] Du WW, Yang W, Liu E et al. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res 2016; 44:2846-58. https://doi.org/10.1093/nar/gkw027

[14] Legnini I, Di Timoteo G, Rossi F et al. Circ-ZNF609 is a circular RNA that can Be translated and functions in myogenesis. Mol Cell 2017; 66:22-37.e29. https://doi.org/10.1016/j.molcel.2017.02.017

[15] Pamudurti NR, Bartok O, Jens M et al. Translation of circRNAs. Mol Cell 2017; 66:9-21.e27. https://doi.org/10.1016/j.molcel.2017.02.021

[16] Yang Y, Fan X, Mao M et al. Extensive translation of circular RNAs driven by N(6)-methyladenosine. Cell Res 2017; 27:626-41. https://doi.org/10.1038/cr.2017.31

[17] Kristensen LS, Jakobsen T, Hager H et al. The emerging roles of circRNAs in cancer and oncology. Nat Rev Clin Oncol 2022; 19:188-206. https://doi.org/10.1038/s41571-021-00585-y

[18] Liu CX, Chen LL. Circular RNAs: characterization, cellular roles, and applications. Cell 2022; 185:2016-34. https://doi.org/10.1016/j.cell.2022.04.021

[19] Ashley EA. Towards precision medicine. Nat Rev Genet 2016; 17:507-22. https://doi.org/10.1038/nrg.2016.86

[20] Torkamani A, Wineinger NE, Topol EJ. The personal and clinical utility of polygenic risk scores. Nat Rev Genet 2018; 19:581-90. https://doi.org/10.1038/s41576-018-0018-x

[21] Popp JM, Rhodes K, Jangi R et al. Cell type and dynamic state govern genetic regulation of gene expression in heterogeneous differentiating cultures. Cell Genom 2024; 4:100701. https://doi.org/10.1016/j.xgen.2024.100701

[22] Findley AS, Monziani A, Richards AL et al. Functional dynamic genetic effects on gene regulation are specific to particular cell types and environmental conditions. eLife 2021; 10:e67077. https://doi.org/10.7554/eLife.67077

[23] Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol 2014; 32:453-61. https://doi.org/10.1038/nbt.2890

[24] Conn SJ, Pillman KA, Toubia J et al. The RNA binding protein quaking regulates formation of circRNAs. Cell 2015; 160:1125-34. https://doi.org/10.1016/j.cell.2015.02.014

[25] Barrett SP, Wang PL, Salzman J. Circular RNA biogenesis can proceed through an exon-containing lariat precursor. eLife 2015; 4:e07540. https://doi.org/10.7554/eLife.07540

[26] Zhang Y, Zhang XO, Chen T et al. Circular intronic long noncoding RNAs. Mol Cell 2013; 51:792-806. https://doi.org/10.1016/j.molcel.2013.08.017

[27] Li Z, Huang C, Bao C et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol 2015; 22:256-64. https://doi.org/10.1038/nsmb.2959

[28] Chen N, Zhao G, Yan X et al. A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1. Genome Biol 2018; 19:218. https://doi.org/10.1186/s13059-018-1594-y

[29] Yang Q, Du WW, Wu N et al. A circular RNA promotes tumorigenesis by inducing c-myc nuclear translocation. Cell Death Differ 2017; 24:1609-20. https://doi.org/10.1038/cdd.2017.86

[30] Hong X, Li Q, Li J et al. CircIPO7 promotes nasopharyngeal carcinoma metastasis and cisplatin chemoresistance by facilitating YBX1 nuclear localization. Clin Cancer Res 2022; 28:4521-35. https://doi.org/10.1158/1078-0432.CCR-22-0991

[31] Wang X, Li J, Bian X et al. CircURI1 interacts with hnRNPM to inhibit metastasis by modulating alternative splicing in gastric cancer. Proc Natl Acad Sci USA 2021; 118:e2012881118. https://doi.org/10.1073/pnas.2012881118

[32] Li B, Zhu L, Lu C et al. circNDUFB2 inhibits non-small cell lung cancer progression via destabilizing IGF2BPs and activating anti-tumor immunity. Nat Commun 2021; 12:295. https://doi.org/10.1038/s41467-020-20527-z

[33] Wu N, Yuan Z, Du KY et al. Translation of yes-associated protein (YAP) was antagonized by its circular RNA via suppressing the assembly of the translation initiation machinery. Cell Death Differ 2019; 26:2758-73. https://doi.org/10.1038/s41418-019-0337-2

[34] Fan X, Yang Y, Chen C et al. Pervasive translation of circular RNAs driven by short IRES-like elements. Nat Commun 2022; 13:3751. https://doi.org/10.1038/s41467-022-31327-y

[35] Huang W, Ling Y, Zhang S et al. TransCirc: an interactive database for translatable circular RNAs based on multiomics evidence. Nucleic Acids Res 2021; 49:D236-42. https://doi.org/10.1093/nar/gkaa823

[36] Wen SY, Qadir J, Yang BB. Circular RNA translation: novel protein isoforms and clinical significance. Trends Mol Med 2022; 28:405-20. https://doi.org/10.1016/j.molmed.2022.03.003

[37] Margvelani G, Maquera KAA, Welden JR et al. Translation of circular RNAs. Nucleic Acids Res 2025; 53:gkae1167. https://doi.org/10.1093/nar/gkae1167

[38] Li K, Peng ZY, Wang R et al. Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of wnt signaling by circ-FBXW7. Mol Cancer 2023; 22:103. https://doi.org/10.1186/s12943-023-01811-039.GaoX,XiaX, Li F et al. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling. Nat Cell Biol 2021; 23:278-91. https://doi.org/10.1038/s41556-021-00639-4

[39] Du WW, Xu J, Yang W et al. A neuroligin isoform translated by circNlgn contributes to cardiac remodeling. Circ Res 2021; 129:568-82. https://doi.org/10.1161/CIRCRESAHA.120.318364

[40] Huang D, Zhu X, Ye S et al. Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides. Nature 2024; 625:593-602. https://doi.org/10.1038/s41586-023-06834-7

[41] Conn VM, Chinnaiyan AM, Conn SJ. Circular RNA in cancer. Nat Rev Cancer 2024; 24:597-613. https://doi.org/10.1038/s41568-024-00721-7

[42] Li K, Guo J, Ming Y et al. A circular RNA activated by TGFbeta promotes tumor metastasis through enhancing IGF2BP3- mediated PDPN mRNA stability. Nat Commun 2023; 14:6876. https://doi.org/10.1038/s41467-023-42571-1

[43] Jian X, He H, Zhu J et al. Hsa_circ_001680 affects the proliferation and migration of CRC and mediates its chemoresistance by regulating BMI1 through miR-340. Mol Cancer 2020; 19:20. https://doi.org/10.1186/s12943-020-1134-8

[44] Xu X, Peng Q, Ren Z et al. CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance. Mol Cancer 2025; 24:36. https://doi.org/10.1186/s12943-025-02239-4

[45] Guo J, Li K, Ming Y et al. A circular RNA overcomes acquired resistance to BET inhibitors by antagonizing IGF2BP2- mediated c-MYC translation in TNBC. Proc Natl Acad Sci USA 2025; 122:e2504320122. https://doi.org/10.1073/pnas.2504320122

[46] Zhang Y, Jiang J, Zhang J et al. CircDIDO1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Mol Cancer 2021; 20:101. https://doi.org/10.1186/s12943-021-01390-y

[47] Liu YY, Zhang YY, Ran LY et al. A novel protein FNDC3B- 267aa encoded by circ0003692 inhibits gastric cancer metastasis via promoting proteasomal degradation of c-Myc. J Transl Med 2024; 22:507. https://doi.org/10.1186/s12967-024-05225-4

[48] Tan WL, Lim BT, Anene-Nzelu CG et al. A landscape of circular RNA expression in the human heart. Cardiovasc Res 2017; 113:298-309. https://doi.org/10.1093/cvr/cvw250

[49] Long Q, Lv B, Jiang S et al. The landscape of circular RNAs in cardiovascular diseases. Int J Mol Sci 2023; 24:4571. https://doi.org/10.3390/ijms24054571

[50] Huang S, Li X, Zheng H et al. Loss of super-enhancerregulated circRNA nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation 2019; 139:2857-76. https://doi.org/10.1161/CIRCULATIONAHA.118.038361

[51] Garikipati VNS, Verma SK, Cheng Z et al. Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis. Nat Commun 2019; 10:4317. https://doi.org/10.1038/s41467-019-11777-7

[52] Sygitowicz G, Sitkiewicz D. Involvement of circRNAs in the development of heart failure. Int J Mol Sci 2022; 23:14129. https://doi.org/10.3390/ijms232214129

[53] Du WW, Rafiq M, Yuan H et al. A novel protein NAB1-356 encoded by circRNA circNAB1 mitigates atrial fibrillation by reducing inflammation and fibrosis. Adv Sci 2025; 12:e2411959. https://doi.org/10.1002/advs.202411959

[54] Khan MA, Reckman YJ, Aufiero S et al. RBM20 Regulates circular RNA production from the Titin gene. Circ Res 2016; 119:996-1003. https://doi.org/10.1161/CIRCRESAHA.116.309568

[55] Gao XQ, Liu CY, Zhang YH et al. The circRNA CNEACR regulates necroptosis of cardiomyocytes through Foxa 2 suppression. Cell Death Differ 2022; 29:527-39. https://doi.org/10.1038/s41418-021-00872-2

[56] Wu N, Xu J, Du WW et al. YAP circular RNA, circYap, attenuates cardiac fibrosis via binding with tropomyosin-4 and gamma-actin decreasing actin polymerization. Mol Ther 2021; 29:1138-50. https://doi.org/10.1016/j.ymthe.2020.12.004

[57] Gonzalez C, Cimini M, Mallaredy V et al. Circular RNA Cdr1as modulates macrophage-mediated cardiac reparative function. Circ Res 2025; 137:1207-21. https://doi.org/10.1161/CIRCRESAHA.125.326377

[58] Dandare A, Rafiq M, Liaquat A et al. Identification of hsa_circ_0092576 regulatory network in the pathogenesis of coronary heart disease. Genes Dis 2023; 10:26-8. https://doi.org/10.1016/j.gendis.2021.12.027

[59] Kelly D, Bicker S, Winterer J et al. A functional screen uncovers circular RNAs regulating excitatory synaptogenesis in hippocampal neurons. Nat Commun 2025; 16:3040. https://doi.org/10.1038/s41467-025-58070-4

[60] Wang G, Han B, Shen L et al. Silencing of circular RNA HIPK2 in neural stem cells enhances functional recovery following ischaemic stroke. EBioMedicine 2020; 52:102660. https://doi.org/10.1016/j.ebiom.2020.102660

[61] Feng X, Jiang BW, Zhai SN et al. Circular RNA aptamers targeting neuroinflammation ameliorate Alzheimer disease phenotypes in mouse models. Nat Biotechnol 2026; 44:454-63. https://doi.org/10.1038/s41587-025-02624-w

[62] Dube U, Del-Aguila JL, Li Z et al. An atlas of cortical circular RNA expression in Alzheimer disease brains demonstrates clinical and pathological associations. Nat Neurosci 2019; 22:1903-12. https://doi.org/10.1038/s41593-019-0501-5

[63] Hanan M, Simchovitz A, Yayon N et al. A Parkinson’s disease CircRNAs resource reveals a link between circSLC8A1 and oxidative stress. EMBO Mol Med 2020; 12:e11942. https://doi.org/10.15252/emmm.201911942

[64] Mehta SL, Pandi G, Vemuganti R. Circular RNA expression profiles alter significantly in mouse brain after transient focal ischemia. Stroke 2017; 48:2541-8. https://doi.org/10.1161/STROKEAHA.117.017469

[65] Han B, Zhang Y, Zhang Y et al. Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke. Autophagy 2018; 14:1164-84. https://doi.org/10.1080/15548627.2018.1458173

[66] Tan L, Zhao W, Wang H et al. Dysfunctional circular RNA network in major depressive disorder: dissecting the cell identity and potential clinical applications. Mol Psychiatry 2026; 31:498-513. https://doi.org/10.1038/s41380-025-03167-x

[67] Smid M, Wilting SM, Uhr K et al. The circular RNome of primary breast cancer. Genome Res 2019; 29:356-66. https://doi.org/10.1101/gr.238121.118

[68] Sonnenschein K, Wilczek AL, de Gonzalo-Calvo D et al. Serum circular RNAs act as blood-based biomarkers for hypertrophic obstructive cardiomyopathy. Sci Rep 2019; 9:20350. https://doi.org/10.1038/s41598-019-56617-2

[69] Luo YH, Yang YP, Chien CS et al. Plasma level of circular RNA hsa_circ_0000190 correlates with tumor progression and poor treatment response in advanced lung cancers. Cancers 2020; 12:1740. https://doi.org/10.3390/cancers12071740

[70] He J, Ma S, Kuai S et al. Circular RNA circAHSA1 serves as a stable serum biomarker for the diagnosis and progression of gastric cancer. Transl Oncol 2026; 63:102620. https://doi.org/10.1016/j.tranon.2025.102620

[71] Vausort M, Salgado-Somoza A, Zhang L et al. Myocardial infarction-associated circular RNA predicting left ventricular dysfunction. J Am Coll Cardiol 2016; 68:1247-8. https://doi.org/10.1016/j.jacc.2016.06.040

[72] Hessels D, Klein Gunnewiek JM, van Oort I et al. DD3(PCA3)- based molecular urine analysis for the diagnosis of prostate cancer. Eur Urol 2003; 44:8-15. https://doi.org/10.1016/s0302-2838(03)00201-x

[73] Groskopf J, Aubin SM, Deras IL et al. APTIMA PCA3 molecular urine test: development of a method to aid in the diagnosis of prostate cancer. Clin Chem 2006; 52:1089-95. https://doi.org/10.1373/clinchem.2005.063289

[74] Tian L, Xu F, Lu Y et al. Exploring a circulating circRNA and miRNA biomarker panel for early detection of ovarian cancer through multiple omics analysis. Sci Rep 2025; 15:25809. https://doi.org/10.1038/s41598-025-11641-3

[75] Rossi F, Legnini I, Megiorni F et al. Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma. Oncogene 2019; 38:3843-54. https://doi.org/10.1038/s41388-019-0699-4

[76] Li Y, Zheng F, Xiao X et al. CircHIPK3 sponges miR-558 to suppress heparanase expression in bladder cancer cells. EMBO Rep 2017; 18:1646-59. https://doi.org/10.15252/embr.201643581

[77] Chen G, Shi Y, Liu M et al. circHIPK3 regulates cell proliferation and migration by sponging miR-124 and regulating AQP3 expression in hepatocellular carcinoma. Cell Death Dis 2018; 9:175. https://doi.org/10.1038/s41419-017-0204-3

[78] Lovendorf MB, Holm A, Petri A et al. Knockdown of circular RNAs using LNA-modified antisense oligonucleotides. Nucleic Acid Ther 2023; 33:45-57. https://doi.org/10.1089/nat.2022.0040

[79] Cao SQ, Xue ST, Li WJ et al. CircHIPK3 regulates fatty acid metabolism through miR-637/FASN axis to promote esophageal squamous cell carcinoma. Cell Death Discov 2024; 10:110. https://doi.org/10.1038/s41420-024-01881-z

[80] Yi J, Du J, Chen X et al. A circRNA-mRNA pairing mechanism regulates tumor growth and endocrine therapy resistance in ER-positive breast cancer. Proc Natl Acad Sci USA 2025; 122:e2420383122. https://doi.org/10.1073/pnas.2420383122

[81] Wu N, Li F, Yang W et al. Silencing mouse circular RNA circ- Slc8a1 by circular antisense cA-circSlc8a1 induces cardiac hepatopathy. Mol Ther 2023; 31:1688-704. https://doi.org/10.1016/j.ymthe.2022.10.005

[82] Kim T, Yum K, Lee JB. Therapeutic potential of circular antisense oligonucleotides in gene silencing and RNA condensate degradation. Int J Biol Macromol 2025; 322:146970. https://doi.org/10.1016/j.ijbiomac.2025.146970

[83] Koch L. CRISPR-Cas13 targets circRNAs. Nat Rev Genet 2021; 22:68. https://doi.org/10.1038/s41576-020-00318-4

[84] Li S, Li X, Xue W et al. Screening for functional circular RNAs using the CRISPR-Cas13 system. Nat Methods 2021; 18:51-9. https://doi.org/10.1038/s41592-020-01011-4

[85] Zhang Y, Nguyen TM, Zhang XO et al. Optimized RNAtargeting CRISPR/Cas13d technology outperforms shRNA in identifying functional circRNAs. Genome Biol 2021; 22:41. https://doi.org/10.1186/s13059-021-02263-9

[86] Ai Y, Liang D, Wilusz JE. CRISPR/Cas13 effectors have differing extents of off-target effects that limit their utility in eukaryotic cells. Nucleic Acids Res 2022; 50:e65. https://doi.org/10.1093/nar/gkac159

[87] Wessels HH, Mendez-Mancilla A, Guo X et al. Massively parallel Cas13 screens reveal principles for guide RNA design. Nat Biotechnol 2020; 38:722-7. https://doi.org/10.1038/s41587-020-0456-9

[88] Lee-Yow YC, Valbuena RC, Richter CS et al. Junctiontargeting designs limit the application of CRISPR-Cas13d in circular RNA perturbation studies. Nucleic Acids Res 2026; 54:gkaf1447. https://doi.org/10.1093/nar/gkaf1447

[89] Chen S, Huang V, Xu X et al. Widespread and functional RNA circularization in localized prostate cancer. Cell 2019; 176:831-43. https://doi.org/10.1016/j.cell.2019.01.025

[90] Gu Y, Wang Y, He L et al. Circular RNA circIPO11 drives selfrenewal of liver cancer initiating cells via hedgehog signaling. Mol Cancer 2021; 20:132. https://doi.org/10.1186/s12943-021-01435-2

[91] Abudayyeh OO, Gootenberg JS, Essletzbichler P et al. RNA targeting with CRISPR-Cas13. Nature 2017; 550:280-4. https://doi.org/https://doi.org/10.1038/nature24049

[92] Cox DBT, Gootenberg JS, Abudayyeh OO et al. RNA editing with CRISPR-Cas13. Science 2017; 358:1019-27. https://doi.org/10.1126/science.aaq0180

[93] He AT, Liu J, Li F et al. Targeting circular RNAs as a therapeutic approach: current strategies and challenges. Signal Transduct Target Ther 2021; 6:185. https://doi.org/10.1038/s41392-021-00569-5

[94] Liu X, Wang S, Sun Y et al. Unlocking the potential of circular RNA vaccines: a bioinformatics and computational biology perspective. EBioMedicine 2025; 114:105638. https://doi.org/10.1016/j.ebiom.2025.105638

[95] Gong Z, Hu W, Zhou C et al. Recent advances and perspectives on the development of circular RNA cancer vaccines. NPJ Vaccines 2025; 10:41. https://doi.org/10.1038/s41541-025-01097-x

[96] Chen CK, Cheng R, Demeter J et al. Structured elements drive extensive circular RNA translation. Mol Cell 2021; 81:4300-18. https://doi.org/10.1016/j.molcel.2021.07.042

[97] Wang Y, Wu C, Du Y et al. Expanding uncapped translation and emerging function of circular RNA in carcinomas and noncarcinomas. Mol Cancer 2022; 21:13. https://doi.org/10.1186/s12943-021-01484-7

[98] Li M, Ding W, Fang X et al. Novel truncated peptide derived from circCDYL exacerbates cardiac hypertrophy. Circ Res 2025; 136:e94-e112. https://doi.org/10.1161/CIRCRESAHA.124.325573

[99] Yang Y, Gao X, Zhang M et al. Novel role of FBXW7 circular RNA in repressing glioma tumorigenesis. J Natl Cancer Inst 2018; 110:304-15. https://doi.org/10.1093/jnci/djx166

[100] Carter PJ, Lazar GA. Next generation antibody drugs: pursuit of the ‘high-hanging fruit’. Nat Rev Drug Discov 2018; 17:197-223. https://doi.org/10.1038/nrd.2017.227

[101] Santos R, Ursu O, Gaulton A et al. A comprehensive map of molecular drug targets. Nat Rev Drug Discov 2017; 16:19-34. https://doi.org/10.1038/nrd.2016.230

[102] Dou J, Tan Y, Kock KH et al. Single-nucleotide variant calling in single-cell sequencing data with Monopogen. Nat Biotechnol 2024; 42:803-12. https://doi.org/10.1038/s41587-023-01873-x

[103] Di Timoteo G, Dattilo D, Centron-Broco A et al. Modulation of circRNA metabolism by m(6)A modification. Cell Rep 2020; 31:107641. https://doi.org/10.1016/j.celrep.2020.107641

[104] Zhong J, Wu X, Gao Y et al. Circular RNA encoded MET variant promotes glioblastoma tumorigenesis. Nat Commun 2023; 14:4467. https://doi.org/10.1038/s41467-023-40212-1

[105] Lin HH, Chang CY, Huang YR et al. Exon junction complex mediates the cap-independent translation of circular RNA. Mol Cancer Res 2023; 21:1220-33. https://doi.org/10.1158/1541-7786.MCR-22-0877

[106] Chang J, Shin MK, Park J et al. An interaction between eIF4A3 and eIF3g drives the internal initiation of translation. Nucleic Acids Res 2023; 51:10950-69. https://doi.org/10.1093/nar/gkad763

[107] Song Z, Lin J, Su R et al. eIF3j inhibits translation of a subset of circular RNAs in eukaryotic cells. Nucleic Acids Res 2022; 50:11529-49. https://doi.org/10.1093/nar/gkac980

[108] Liu Y, Li Z, Zhang M et al. Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity. Neuro Oncol 2021; 23:743-56. https://doi.org/10.1093/neuonc/noaa279

[109] Abe N, Matsumoto K, Nishihara M et al. Rolling circle translation of circular RNA in living Human cells. Sci Rep 2015; 5:16435. https://doi.org/10.1038/srep16435

[110] Du Y, Zuber PK, Xiao H et al. Efficient circular RNA synthesis for potent rolling circle translation. Nat Biomed Eng 2025; 9:1062-74. https://doi.org/10.1038/s41551-024-01306-3

[111] Duan JL, Chen W, Xie JJ et al. A novel peptide encoded by N6 - methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Mol Cancer 2022; 21:93. https://doi.org/10.1186/s12943-022-01537-5

[112] Zang X, He XY, Xiao CM et al. Circular RNA-encoded oncogenic PIAS1 variant blocks immunogenic ferroptosis by modulating the balance between SUMOylation and phosphorylation of STAT1. Mol Cancer 2024; 23:207. https://doi.org/10.1186/s12943-024-02124-6

[113] Li F, Du WW, Li X et al. A new protein isoform encoded by human circular RNA circSLC8a1 contributes to cardiac remodelling. Cardiovasc Res 2025; 121:882-99. https://doi.org/10.1093/cvr/cvaf058

[114] Wang SF, Yang LY, Zhao AQ et al. A novel hidden protein p- 414aa encoded by circSETD2(14,15) inhibits vascular remodeling. Circulation 2025; 151:1568-82. https://doi.org/10.1161/CIRCULATIONAHA.124.070243

[115] Chen R, Wang SK, Belk JA et al. Engineering circular RNA for enhanced protein production. Nat Biotechnol 2023; 41:262-72. https://doi.org/10.1038/s41587-022-01393-0

[116] Cai J, Qiu Z, Chi-Shing Cho W et al. Synthetic circRNA therapeutics: innovations, strategies, and future horizons. Med- Comm (2020) 2024; 5:e720. https://doi.org/10.1002/mco2.720

[117] Choi SW, Nam JW. Optimal design of synthetic circular RNAs. Exp Mol Med 2024; 56:1281-92. https://doi.org/10.1038/s12276-024-01251-w

[118] Wesselhoeft RA, Kowalski PS, Parker-Hale FC et al. RNA circularization diminishes immunogenicity and can extend translation duration in vivo. Mol Cell 2019; 74:508-20. https://doi.org/10.1016/j.molcel.2019.02.015

[119] Wesselhoeft RA, Kowalski PS, Anderson DG. Engineering circular RNA for potent and stable translation in eukaryotic cells. Nat Commun 2018; 9:2629. https://doi.org/10.1038/s41467-018-05096-6

[120] Qu L, Yi Z, Shen Y et al. Circular RNA vaccines against SARSCoV- 2 and emerging variants. Cell 2022; 185:1728-44. https://doi.org/10.1016/j.cell.2022.03.044

[121] Tai J, Chen YG. Differ ences in the immunogenicity of engineered circular RNAs. J Mol Cell Biol 2023; 15:mjad002. https://doi.org/10.1093/jmcb/mjad002

[122] Niu D, Wu Y, Lian J. Circular RNA vaccine in disease prevention and treatment. Signal Transduct Target Ther 2023; 8:341. https://doi.org/10.1038/s41392-023-01561-x

[123] Hou X, Zaks T, Langer R et al. Lipid nanoparticles for mRNA delivery. Nat Rev Mater 2021; 6:1078-94. https://doi.org/10.1038/s41578-021-00358-0

[124] Han X, Gong N, Xue L et al. Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis. Nat Commun 2023; 14:75. https://doi.org/10.1038/s41467-022-35637-z

[125] Guo D, Xu W, Cui T et al. Protein-coding circular RNA enhances antiviral immunity via JAK/STAT pathway in Drosophila. mBio 2024; 15:e0146924. https://doi.org/10.1128/mbio.01469-24

[126] Lavenniah A, Luu TDA, Li YP et al. Engineered circular RNA sponges act as miRNA inhibitors to attenuate pressure overload-induced cardiac hypertrophy. Mol Ther 2020; 28:1506-17. https://doi.org/10.1016/j.ymthe.2020.04.006

[127] Guo SK, Liu CX, Xu YF et al. Therapeutic application of circular RNA aptamers in a mouse model of psoriasis. Nat Biotechnol 2025; 43:236-46. https://doi.org/10.1038/s41587-024-02204-4

[128] Meganck RM, Borchardt EK, Castellanos Rivera RM et al. Tissue-dependent expression and translation of circular RNAs with recombinant AAV vectors in vivo. Mol Ther Nucleic Acids 2018; 13:89-98. https://doi.org/10.1016/j.omtn.2018.08.008

[129] Zeng Z, Xia L, Fan S et al. Circular RNA CircMAP3K5 acts as a MicroRNA-22-3p sponge to promote resolution of intimal hyperplasia via TET2-mediated smooth muscle cell differ entiation. Circulation 2021; 143:354-71. https://doi.org/10.1161/CIRCULATIONAHA.120.049715

[130] Wang D, Tai PWL, Gao G. Adeno-associated virus vector as a platform for gene therapy delivery. Nat Rev Drug Discov 2019; 18:358-78. https://doi.org/10.1038/s41573-019-0012-9

[131] Henry TD, Chung ES, Alvisi M et al. Cardiotropic AAV gene therapy for heart failure: a phase 1 trial. Nat Med 2025; 31:3845-52. https://doi.org/10.1038/s41591-025-04011-z

[132] Milone MC, O’Doherty U. Clinical use of lentiviral vectors. Leukemia 2018; 32:1529-41. https://doi.org/10.1038/s41375-018-0106-0

[133] Sano-Fujimoto Y, Nishida Y, Kodama K et al. Advancing ex vivo gene therapy: the role of lentiviral vectors and organizational collaboration. Drug Discov Today 2025; 30:104510. https://doi.org/10.1016/j.drudis.2025.104510

[134] Mecozzi N, Nenci A, Vera O et al. Genetic tools for the stable overexpression of circular RNAs. RNA Biol 2022; 19:353-63. https://doi.org/10.1080/15476286.2022.2043041

[135] Zuckerman JE, Gritli I, Tolcher A et al. Correlating animal and human phase ia/Ib clinical data with CALAA-01, a targeted, polymer-based nanoparticle containing siRNA. Proc Natl Acad Sci USA 2014; 111:11449-54. https://doi.org/10.1073/pnas.1411393111

[136] Kamerkar S, LeBleu VS, Sugimoto H et al. Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer. Nature 2017; 546:498-503. https://doi.org/10.1038/nature22341

[137] Alvarez-Erviti L, Seow Y, Yin H et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol 2011; 29:341-5. https://doi.org/10.1038/nbt.1807

[138] Vasileva O, Zaborova O, Shmykov B et al. Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics. Front Pharmacol 2024; 15:1466337. https://doi.org/10.3389/fphar.2024.1466337

[139] Beach MA, Nayanathara U, Gao Y et al. Polymeric nanoparticles for drug delivery. Chem Rev 2024; 124:5505-616. https://doi.org/10.1021/acs.chemrev.3c00705

[140] Forenzo C, Arnold N, Larsen J. Emerging polymeric nanocarriers for mRNA and protein therapeutics: design, challenges, and clinical outlook. Nanomedicine 2025; 20:2357-74. https://doi.org/10.1080/17435889.2025.2542110

[141] Komuro H, Kawai-Harada Y, Aminova S et al. Engineering extracellular vesicles to target pancreatic tissue in vivo. Nanotheranostics 2021; 5:378-90. https://doi.org/10.7150/ntno.54879

[142] Iqbal Z, Rehman K, Mahmood A et al. Exosome for mRNA delivery: strategies and therapeutic applications. J Nanobiotechnol 2024; 22:395. https://doi.org/10.1186/s12951-024-02634-x

[143] Xu G, Jin J, Fu Z et al. Extracellular vesicle-based drug overview: research landscape, quality control and nonclinical evaluation strategies. Signal Transduct Target Ther 2025; 10:255. https://doi.org/10.1038/s41392-025-02312-w

[144] Wang Y, Xiong J, Ouyang K et al. Extracellular vesicles: from large-scale production and engineering to clinical applications. J Tissue Eng 2025; 16:1-20. https://doi.org/10.1177/20417314251319474

[145] Moazzam M, Zhang M, Hussain A et al. The landscape of nanoparticle-based siRNA delivery and therapeutic development. Mol Ther 2024; 32:284-312. https://doi.org/10.1016/j.ymthe.2024.01.005

[146] Aufiero S, Reckman YJ, Pinto YM et al. Circular RNAs open a new chapter in cardiovascular biology. Nat Rev Cardiol 2019; 16:503-14. https://doi.org/10.1038/s41569-019-0185-2

[147] Wen G, Zhou T, Gu W. The potential of using blood circular RNA as liquid biopsy biomarker for human diseases. Protein Cell 2021; 12:911-46. https://doi.org/10.1007/s13238-020-00799-3

[148] Crooke ST, Liang XH, Baker BF et al. Antisense technology: a review. J Biol Chem 2021; 296:100416. https://doi.org/10.1016/j.jbc.2021.100416

[149] Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov 2020; 19:673-94. https://doi.org/10.1038/s41573-020-0075-7

[150] Sato K, Hamada M. Recent trends in RNA informatics: a review of machine learning and deep learning for RNA secondary structure prediction and RNA drug discovery. Brief Bioinform 2023; 24:bbad186. https://doi.org/10.1093/bib/bbad186

[151] Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet 2016; 17:679-92. https://doi.org/10.1038/nrg.2016.114

[152] Dal Molin A, Gaffo E, Difilippo V et al. CRAFT: a bioinformatics software for custom prediction of circular RNA functions. Brief Bioinform 2022; 23:bbab601. https://doi.org/10.1093/bib/bbab601

[153] Zhu Z, Liang X, Ma R et al. CircCode3: integrating deep learning to mine and evaluate translatable circular RNAs from ribosome profiling sequencing and mass spectrometry data. Brief Bioinform 2025; 26:bbaf458. https://doi.org/10.1093/bib/bbaf458

[154] Yuan L, Yang Y. DeCban: prediction of circRNA-RBP interaction sites by using double embeddings and cross-branch attention networks. Front Genet 2020; 11:632861. https://doi.org/10.3389/fgene.2020.632861

[155] Dudekula DB, Panda AC, Grammatikakis I et al. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol 2016; 13:34-42. https://doi.org/10.1080/15476286.2015.1128065

[156] Forrest IS, Vy HMT, Rocheleau G et al. Machine learning-based penetrance of genetic variants. Science 2025; 389:eadm7066. https://doi.org/10.1126/science.adm7066

[157] Fountzilas E, Pearce T, Baysal MA et al. Convergence of evolving artificial intelligence and machine learning techniques in precision oncology. NPJ Digit Med 2025; 8:75. https://doi.org/10.1038/s41746-025-01471-y

[158] Springer AD, Dowdy SF. GalNAc-siRNA conjugates: leading the way for delivery of RNAi therapeutics. Nucleic Acid Ther 2018; 28:109-18. https://doi.org/10.1089/nat.2018.0736

[159] Janssen HL, Reesink HW, Lawitz EJ et al. Treatment of HCV infection by targeting microRNA. N Engl J Med 2013; 368:1685-94. https://doi.org/10.1056/NEJMoa1209026

[160] Hong DS, Kang YK, Borad M et al. Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer 2020; 122:1630-7. https://doi.org/10.1038/s41416-020-0802-1

[161] Yang L, Han B, Zhang Z et al. Extracellular vesicle-mediated delivery of circular RNA SCMH 1 promotes functional recovery in rodent and nonhuman primate ischemic stroke models. Circulation 2020; 142:556-74. https://doi.org/10.1161/CIRCULATIONAHA.120.045765

[162] Fei D, Wang F, Wang Y et al. Circular RNA ACVR2A promotes the progression of hepatocellular carcinoma through mir-511-5p targeting PI3K-akt signaling pathway. Mol Cancer 2024; 23:159. https://doi.org/10.1186/s12943-024-02074-z

[163] Palcau AC, Pulito C, De Pascale V et al. CircPVT1 weakens miR-33a-5p unleashing the c-MYC/GLS1 metabolic axis in breast cancer. J Exp Clin Cancer Res 2025; 44:100. https://doi.org/10.1186/s13046-025-03355-1

[164] Liu Z, Wang T, She Y et al. N(6)-methyladenosine-modified circIGF2BP3 inhibits CD8( + ) T-cell responses to facilitate tumor immune evasion by promoting the deubiquitination of PD-L1 in non-small cell lung cancer. Mol Cancer 2021; 20:105. https://doi.org/10.1186/s12943-021-01398-4

[165] Yang C, Wu S, Mou Z et al. Exosome-derived circTRPS1 promotes malignant phenotype and CD8 + T cell exhaustion in bladder cancer microenvironments. Mol Ther 2022; 30:1054-70. https://doi.org/10.1016/j.ymthe.2022.01.022

[166] Li H, Jiao W, Song J et al. circ-hnRNPU inhibits NONOmediated c-myc transactivation and mRNA stabilization essential for glycosylation and cancer progression. J Exp Clin Cancer Res 2023; 42:313. https://doi.org/10.1186/s13046-023-02898-5

[167] Wang X, Xing L, Yang R et al. The circACTN4 interacts with FUBP1 to promote tumorigenesis and progression of breast cancer by regulating the expression of proto-oncogene MYC. Mol Cancer 2021; 20:91. https://doi.org/10.1186/s12943-021-01383-x

[168] Du WW, Yang W, Li X et al. A circular RNA circ-DNMT1 enhances breast cancer progression by activating autophagy. Oncogene 2018; 37:5829-42. https://doi.org/10.1038/s41388-018-0369-y

[169] Cao M, Yuan GH, Cao SM et al. Direct circMAN1A2(2,3,4,5)- CENPB mRNA interaction regulates cell proliferation and cancer progression. Nat Commun 2025; 16:8609. https://doi.org/10.1038/s41467-025-63686-7

[170] Ma J, Du WW, Zeng K et al. An antisense circular RNA circ- SCRIB enhances cancer progression by suppressing parental gene splicing and translation. Mol Ther 2021; 29:2754-68. https://doi.org/10.1016/j.ymthe.2021.08.002

[171] Yu J, Li W, Hou GJ et al. Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation. Exp Mol Med 2023; 55:2390-401. https://doi.org/10.1038/s12276-023-01108-8

[172] Teng M, Guo J, Xu X et al. Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation. Cancer Cell 2025; 43:891-904. https://doi.org/10.1016/j.ccell.2025.03.027

[173] Chen Q, Wang H, Li Z et al. Circular RNA ACTN4 promotes intrahepatic cholangiocarcinoma progression by recruiting YBX1 to initiate FZD7 transcription. J Hepatol 2022; 76:135-47. https://doi.org/10.1016/j.jhep.2021.08.027

[174] Xiong L, Liu HS, Zhou C et al. A novel protein encoded by circINSIG1 reprograms cholesterol metabolism by promoting the ubiquitin-dependent degradation of INSIG1 in colorectal cancer. Mol Cancer 2023; 22:72. https://doi.org/10.1186/s12943-023-01773-3

[175] Li P, Song R, Yin F et al. circMRPS35 promotes malignant progression and cisplatin resistance in hepatocellular carcinoma. Mol Ther 2022; 30:431-47. https://doi.org/10.1016/j.ymthe.2021.08.027

[176] Wang T, Liu Z, She Y et al. A novel protein encoded by circASK1 ameliorates gefitinib resistance in lung adenocarcinoma by competitively activating ASK1-dependent apoptosis. Cancer Lett 2021; 520:321-31. https://doi.org/10.1016/j.canlet.2021.08.007

[177] Li Y, Wang Z, Su P et al. circ-EIF6 encodes EIF6-224aa to promote TNBC progression via stabilizing MYH9 and activating the wnt/beta-catenin pathway. Mol Ther 2022; 30:415-30. https://doi.org/10.1016/j.ymthe.2021.08.026

[178] Tang X, Deng Z, Ding P et al. A novel protein encoded by circHNRNPU promotes multiple myeloma progression by regulating the bone marrow microenvironment and alternative splicing. J Exp Clin Cancer Res 2022; 41:85. https://doi.org/10.1186/s13046-022-02276-7

[179] Tan S, Gou Q, Pu W et al. Circular RNA F-circEA produced from EML4-ALK fusion gene as a novel liquid biopsy biomarker for non-small cell lung cancer. Cell Res 2018; 28:693-5. https://doi.org/10.1038/s41422-018-0033-7

[180] Jiang Z, Zhong Z, Miao Q et al. circPTPN22 as a novel biomarker and ceRNA in peripheral blood mononuclear cells of rheumatoid arthritis. Mol Med Rep 2021; 24:617. https://doi.org/10.3892/mmr.2021.12256

[181] Jiang B, Zhang J, Sun X et al. Circulating exosomal hsa_circRNA_0039480 is highly expressed in gestational diabetes mellitus and may be served as a biomarker for early diagnosis of GDM. J Transl Med 2022; 20:5. https://doi.org/10.1186/s12967-021-03195-5

[182] Li T, Zhou T, Wu J et al. Plasma exosome-derived circGAPVD1 as a potential diagnostic marker for colorectal cancer. Transl Oncol 2023; 31:101652. https://doi.org/10.1016/j.tranon.2023.101652

[183] Zhang R, Deng B, Shi S et al. Plasma-derived neuronal exosomal CircRNAs as potential biomarkers for Central nervous system infections. J Immunol Res 2025; 2025:9363390. https://doi.org/10.1155/jimr/9363390

[184] Yin W, Luo S, Qiu J et al. Identification of hsa_circRNA_100632 as a novel molecular biomarker for fulminant type 1 diabetes. Front Immunol 2023; 14:1075970. https://doi.org/10.3389/fimmu.2023.1075970

[185] Roy S, Kanda M, Nomura S et al. Diagnostic efficacy of circular RNAs as noninvasive, liquid biopsy biomarkers for early detection of gastric cancer. Mol Cancer 2022; 21:42. https://doi.org/10.1186/s12943-022-01527-7

[186] Chen X, Chen RX, Wei WS et al. PRMT5 Circular RNA promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition. Clin Cancer Res 2018; 24:6319-30. https://doi.org/10.1158/1078-0432.CCR-18-1270

[187] Wen N, Peng D, Xiong X et al. Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring. Signal Transduct Target Ther 2024; 9:107. https://doi.org/10.1038/s41392-024-01814-3

[188] Miao L, Yin RX, Zhang QH et al. A novel circRNA-miRNA-mRNA network identifies circ-YOD1 as a biomarker for coronary artery disease. Sci Rep 2019; 9:18314. https://doi.org/10.1038/s41598-019-54603-2

[189] Salgado-Somoza A, Zhang L, Vausort M et al. The circular RNA MICRA for risk stratification after myocardial infarction. Int J Cardiol Heart Vasc 2017; 17:33-6. https://doi.org/10.1016/j.ijcha.2017.11.001

[190] Zhong AN, Yin Y, Tang BJ et al. CircRNA microarray profiling reveals hsa_circ_0058493 as a novel biomarker for imatinibresistant CML. Front Pharmacol 2021; 12:728916. https://doi.org/10.3389/fphar.2021.728916

[191] Dong Y, Gao Q, Chen Y et al. Identification of CircRNA signature associated with tumor immune infiltration to predict therapeutic efficacy of immunotherapy. Nat Commun 2023; 14:2540. https://doi.org/10.1038/s41467-023-38232-y

[192] Papageorgiou G, Ibrahim EC, Gorgievski V et al. A brainenriched circRNA blood biomarker can predict response to SSRI antidepressants. Mol Psychiatry 2026. https://doi.org/10.1038/s41380-026-03491-w

[193] Li X, Wang S, Cui Y et al. CircRNA signature predicts immunotherapy response in advanced non-small cell lung cancer. Ther Adv Med Oncol 2025; 17. https://doi.org/10.1177/17588359251395920